Paper19253922
Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF and 6 others. Chembiochem, 2009. Cited by 306 papers, by iCite.
Cite this record
ConductScience Library. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Papers, record 19253922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19253922
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Aptamers, Nucleotide | Major topic |
| Doxorubicin | Major topic |
| Drug Delivery Systems | Major topic |
| Neoplasms | Major topic |
| SELEX Aptamer Technique | Major topic |
| Animals | |
| Base Sequence | |
| Cell Line, Tumor | |
| Drug Carriers | |
| Endocytosis | |
| Humans | |
| Immunoconjugates | |
| Molecular Sequence Data | |
| Molecular Structure |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM079359 | NIGMS NIH HHS | United States | R01GM079359 | PubMed and NIH |
Source NIH RePORTER
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16778167 | Aptamer:toxin conjugates that specifically target prostate tumor cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/16778167 | PubMed |
| 2 | 17099918 | An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. | Angew Chem Int Ed Engl | 2006 | https://conductscience.org/library/papers/17099918 | PubMed |
| 3 | 12676579 | Progress in immunoconjugate cancer therapeutics. | Cancer Cell | 2003 | https://conductscience.org/library/papers/12676579 | PubMed |
| 4 | 15828758 | Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions. | Anal Chem | 2005 | https://conductscience.org/library/papers/15828758 | PubMed |
| 5 | 18536555 | Antibody-drug conjugates for cancer therapy. | Cancer J | 2008 | https://conductscience.org/library/papers/18536555 | PubMed |
| 6 | 8564396 | Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro. | Bioorg Med Chem | 1995 | https://conductscience.org/library/papers/8564396 | PubMed |
| 7 | 14676325 | A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14676325 | PubMed |
| 8 | 1697402 | In vitro selection of RNA molecules that bind specific ligands. | Nature | 1990 | https://conductscience.org/library/papers/1697402 | PubMed |
| 9 | 6300903 | pH and the recycling of transferrin during receptor-mediated endocytosis. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6300903 | PubMed |
| 10 | 17463173 | Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. | Clin Chem | 2007 | https://conductscience.org/library/papers/17463173 | PubMed |
| 11 | 16640493 | Nanoparticle-aptamer bioconjugates for cancer targeting. | Expert Opin Drug Deliv | 2006 | https://conductscience.org/library/papers/16640493 | PubMed |
| 12 | 18177018 | Identification of liver cancer-specific aptamers using whole live cells. | Anal Chem | 2008 | https://conductscience.org/library/papers/18177018 | PubMed |
| 13 | 7508268 | (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin. | Bioconjug Chem | 1993 | https://conductscience.org/library/papers/7508268 | PubMed |
| 14 | 17705444 | Targeted cancer therapy: conferring specificity to cytotoxic drugs. | Acc Chem Res | 2008 | https://conductscience.org/library/papers/17705444 | PubMed |
| 15 | 16873550 | Aptamers evolved from live cells as effective molecular probes for cancer study. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16873550 | PubMed |
| 16 | 18363322 | Cell-specific aptamer probes for membrane protein elucidation in cancer cells. | J Proteome Res | 2008 | https://conductscience.org/library/papers/18363322 | PubMed |
| 17 | 18092308 | Cell-specific internalization study of an aptamer from whole cell selection. | Chemistry | 2008 | https://conductscience.org/library/papers/18092308 | PubMed |
| 18 | 2200121 | Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. | Science | 1990 | https://conductscience.org/library/papers/2200121 | PubMed |
| 19 | 18163537 | Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage. | Bioconjug Chem | 2008 | https://conductscience.org/library/papers/18163537 | PubMed |
| 20 | 11279054 | Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11279054 | PubMed |
Cited by149
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 306 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42706252 | Nucleic acid aptamers: new methods for selection, target validation, molecular diagnostics and therapeutics. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42706252 | PubMed |
| 42559290 | Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42559290 | PubMed |
| 42371418 | A CD36-targeted aptamer-4-butyl-polyhydroxybenzophenone conjugate with pH-responsive release for liver delivery in MASLD. | Regen Biomater | 2026 | https://conductscience.org/library/papers/42371418 | PubMed |
| 42294300 | Synthetic short RNA in cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42294300 | PubMed |
| 41820318 | Aptamers in Osteosarcoma: New Paths for Diagnosis and Treatment. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/41820318 | PubMed |
| 41754959 | CD25-Targeted Aptamer-Drug Conjugate for the Treatment of CD25-Expressing Hematological Malignancies. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754959 | PubMed |
| 41306923 | Aptamers in Drug Delivery Development. | Mater Today (Kidlington) | 2025 | https://conductscience.org/library/papers/41306923 | PubMed |
| 41190338 | Covalent aptamers: agents with promising therapeutic and diagnostic potential. | RSC Chem Biol | 2026 | https://conductscience.org/library/papers/41190338 | PubMed |
| 40987771 | An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40987771 | PubMed |
| 40925520 | Aptamers as target-specific recognition elements in drug delivery. | Adv Drug Deliv Rev | 2025 | https://conductscience.org/library/papers/40925520 | PubMed |
| 40870970 | Aptamers Targeting Immune Checkpoints for Tumor Immunotherapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40870970 | PubMed |
| 40563458 | Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery. | Biomolecules | 2025 | https://conductscience.org/library/papers/40563458 | PubMed |
| 40397061 | Improvement of Drug Release from an Aptamer Drug Conjugate Using Reductive-sensitive Linkers for Tumor-targeted Drug Delivery. | AAPS J | 2025 | https://conductscience.org/library/papers/40397061 | PubMed |
| 39572459 | Dual roles of extracellular vesicles in acute lymphoblastic leukemia: implications for disease progression and theranostic strategies. | Med Oncol | 2024 | https://conductscience.org/library/papers/39572459 | PubMed |
| 39434968 | Progressive cancer targeting by programmable aptamer-tethered nanostructures. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39434968 | PubMed |
| 38493153 | Aptamers as an approach to targeted cancer therapy. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38493153 | PubMed |
| 38391997 | Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims. | Biosensors (Basel) | 2024 | https://conductscience.org/library/papers/38391997 | PubMed |
| 38051194 | Enzymatic Synthesis of Aptamer-Polynucleotide Nanoparticles with High Anticancer Drug Loading for Targeted Delivery. | Biomacromolecules | 2024 | https://conductscience.org/library/papers/38051194 | PubMed |
| 37720779 | Recent Advancements of Aptamers in Cancer Therapy. | ACS Omega | 2023 | https://conductscience.org/library/papers/37720779 | PubMed |
| 37538812 | Mechanics of dynamic and deformable DNA nanostructures. | Chem Sci | 2023 | https://conductscience.org/library/papers/37538812 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD33 | 945 | PubTator's text mining | https://conductscience.org/library/genes/945 | NCBI Gene |
| FOLH1 | 2346 | PubTator's text mining | https://conductscience.org/library/genes/2346 | NCBI Gene |
| PTK7 | 5754 | PubTator's text mining | https://conductscience.org/library/genes/5754 | NCBI Gene |
| TF | 7018 | PubTator's text mining | https://conductscience.org/library/genes/7018 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19253922
GET https://conductscience.org/api/papers/v1/19253922/references?page=2